Lynn E. Nooijen , Marieke T. de Boer , Andries E. Braat , Maxime Dewulf , Marcel den Dulk , Jeroen Hagendoorn , Frederik J.H. Hoogwater , Hwai-Ding Lam , Quintus Molenaar , Ulf Neumann , Robert J. Porte , Rutger-Jan Swijnenburg , Babs Zonderhuis , Geert Kazemier , Heinz-josef Klümpen , Thomas van Gulik , Bas Groot Koerkamp , Joris I. Erdmann
{"title":"National consensus on a new resectability classification for perihilar cholangiocarcinoma - A modified Delphi method","authors":"Lynn E. Nooijen , Marieke T. de Boer , Andries E. Braat , Maxime Dewulf , Marcel den Dulk , Jeroen Hagendoorn , Frederik J.H. Hoogwater , Hwai-Ding Lam , Quintus Molenaar , Ulf Neumann , Robert J. Porte , Rutger-Jan Swijnenburg , Babs Zonderhuis , Geert Kazemier , Heinz-josef Klümpen , Thomas van Gulik , Bas Groot Koerkamp , Joris I. Erdmann","doi":"10.1016/j.ejso.2023.107117","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Currently, no practical definition of potentially resectable, borderline or unresectable perihilar cholangiocarcinoma (pCCA) is available. Aim of this study was to define criteria to categorize patients for use in a future neoadjuvant or induction therapy study.</div></div><div><h3>Method</h3><div>Using the modified DELPHI method, hepatobiliary surgeons from all tertiary referral centers in the Netherlands were invited to participate in this study. During five online meetings, predefined factors determining resectability and additional factors regarding surgical resectability and operability were discussed.</div></div><div><h3>Results</h3><div>The five online meetings resulted in 52 statements. After two surveys, consensus was reached in 63% of the questions. The main consensus included a definition regarding potential resectability. 1) Clearly resectable: no vascular involvement (≤90°) of the future liver remnant (FLR) and expected feasibility of radical biliary resection. 2) Clearly unresectable: non-reconstructable venous and/or arterial involvement of the FLR or no feasible radical biliary resection. 3) Borderline resectable: all patients between clearly resectable and clearly unresectable disease.</div></div><div><h3>Conclusion</h3><div>This DELPHI study resulted in a practical and applicable resectability, or more accurate, an explorability classification, which can be used to categorize patients for use in future neoadjuvant therapy studies.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 2","pages":"Article 107117"},"PeriodicalIF":3.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798323007552","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Currently, no practical definition of potentially resectable, borderline or unresectable perihilar cholangiocarcinoma (pCCA) is available. Aim of this study was to define criteria to categorize patients for use in a future neoadjuvant or induction therapy study.
Method
Using the modified DELPHI method, hepatobiliary surgeons from all tertiary referral centers in the Netherlands were invited to participate in this study. During five online meetings, predefined factors determining resectability and additional factors regarding surgical resectability and operability were discussed.
Results
The five online meetings resulted in 52 statements. After two surveys, consensus was reached in 63% of the questions. The main consensus included a definition regarding potential resectability. 1) Clearly resectable: no vascular involvement (≤90°) of the future liver remnant (FLR) and expected feasibility of radical biliary resection. 2) Clearly unresectable: non-reconstructable venous and/or arterial involvement of the FLR or no feasible radical biliary resection. 3) Borderline resectable: all patients between clearly resectable and clearly unresectable disease.
Conclusion
This DELPHI study resulted in a practical and applicable resectability, or more accurate, an explorability classification, which can be used to categorize patients for use in future neoadjuvant therapy studies.
期刊介绍:
JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery.
The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.